Interstitial lung disease as the first manifestation of systemic sclerosis

被引:0
作者
Van der Kamp, R.
Tak, P. P.
Jansen, H. M.
Bresser, P.
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Pulmonol, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands
关键词
interstitial lung disease; scleroderma sine scleroderma; systemic sclerosis;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We describe three patients with progressive fibrosing interstitial lung disease (ILD) as the first and only manifestation of systemic sclerosis. In one patient the presence of anti-Scl-70 autoantibodies suggested systemic sclerosis to be the underlying cause of the disease. In the two other subjects, however, anti-Scl-70 antibodies were negative. in these patients the lung disease preceded other manifestations of systemic sclerosis by several years. Diagnosis, prognosis and treatment of systemic sclerosis-associated ILD is discussed.
引用
收藏
页码:390 / 394
页数:5
相关论文
共 41 条
[1]   PULMONARY INVOLVEMENT IN RHEUMATOID-ARTHRITIS [J].
ANAYA, JM ;
DIETHELM, L ;
ORTIZ, LA ;
GUTIERREZ, M ;
CITERA, G ;
WELSH, RA ;
ESPINOZA, LR .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1995, 24 (04) :242-254
[2]  
*ATA ERS INT MULT, 2002, AM J RESP CRIT CARE, V165, P277
[3]   Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis [J].
Bjoraker, JA ;
Ryu, JH ;
Edwin, MK ;
Myers, JL ;
Tazelaar, HD ;
Schroeder, DR ;
Offord, KP .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (01) :199-203
[4]   Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome [J].
Bouros, D ;
Wells, AU ;
Nicholson, AG ;
Colby, TV ;
Polychronopoulos, V ;
Pantelidis, P ;
Haslam, PL ;
Vassilakis, DA ;
Black, CM ;
du Bois, RM .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (12) :1581-1586
[5]  
Dacic S, 2003, AM J RESP CELL MOL, V29, pS5
[6]   A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis [J].
Daniil, ZD ;
Gilchrist, FC ;
Nicholson, AG ;
Hansell, DM ;
Harris, J ;
Colby, TV ;
du Bois, RM .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (03) :899-905
[7]   Intravenous cyclophosphamide pulse therapy for the treatment of lung disease associated with scleroderma [J].
Davas, EM ;
Peppas, C ;
Maragou, M ;
Alvanou, E ;
Hondros, D ;
Dantis, PC .
CLINICAL RHEUMATOLOGY, 1999, 18 (06) :455-461
[8]   Antinuclear antibody testing in systemic autoimmune disease [J].
Evans, J .
CLINICS IN CHEST MEDICINE, 1998, 19 (04) :613-+
[9]   Non-specific interstitial pneumonia as pulmonary involvement of systemic sclerosis [J].
Fujita, J ;
Yoshinouchi, T ;
Ohtsuki, Y ;
Tokuda, M ;
Yang, Y ;
Yamadori, I ;
Bandoh, S ;
Ishida, T ;
Takahara, J ;
Ueda, R .
ANNALS OF THE RHEUMATIC DISEASES, 2001, 60 (03) :281-283
[10]  
Giacomelli R, 2002, J RHEUMATOL, V29, P731